NASDAQ:GLSI | Free Cash Flow | Greenwich LifeSciences, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2019-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$4.7M
2025-12-31-$3.17M
2025-03-31-$1.83M
2024-12-31-$1.85M
2024-03-31-$1.78M
2023-12-31-$2.15M
2023-03-31-$1.56M
2022-12-31-$2.17M
2022-03-31-$1.95M
2021-12-31-$2.26M
2021-03-31-$528,270.00
2019-12-31-$214,167.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$9.91M
2024-12-31-$7.27M
2023-12-31-$6.48M
2022-12-31-$6.2M
2021-12-31-$4.29M
2020-12-31-$1.15M
2019-12-31-$293,267.00